The initial results of 19 autologous and 1 syngeneic bone marrow transplantations, done in children with neuroblastomas (14), non-Hodgkin's lymphomas (3), Ewing sarcoma (1), acute lymphocytic (1) and non-lymphocytic (1) leukemias, pioneerely started in Brazil in February, 1987, and specially after the beginning of the ICR Marrow Transplantation Program, in October, 1989, are here described. Methodology, toxicity and survival are discussed. The efforts for establishing a high technology program in a public and universitarian institution, deeply supported by the community, are emphasized. Future directions are also discussed.
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See more